References
Armijo JA, Pena MA, Adin J, Vega-Gil N (2004) Association between patient age and gabapentin serum concentrationto- dose ratio: a preliminary multivariate analysis. Ther Drug Monit 26: 633–637
Asconape J, Diedrich A, DellaBadia J (2000) Myoclonus associated with the use of gabapentin. Epilepsia 41:479–481
Gordon MF (2002) Toxin and druginduced myoclonus. Adv Neurol 89:49–76
Huppertz HJ, Feuerstein TJ, Schulze- Bonhage A (2001) Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin. Epilepsia 42:790–792
Rose MA, Kam PC (2002) Gabapentin: pharmacology and its use in pain management. Anaesthesia 57:451–462
Zhang C, Glenn DG, Bell WL, O’Donovan CA (2005) Gabapentin-induced myoclonus in end-stage renal disease. Epilepsia 46:156–158
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Holtkamp, M., Halle, A., Meierkord, H. et al. Gabapentin–induced severe myoclonus in a patient with impaired renal function. J Neurol 253, 382–383 (2006). https://doi.org/10.1007/s00415-005-0970-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-005-0970-1